Targeting the translation machinery in cancer
The DOI matches its Crossref record; 291 of the 291 references it cites were found in a registry or an index.
Abstract
Dysregulation of mRNA translation is a frequent feature of neoplasia. Many oncogenes and tumour suppressors affect the translation machinery, making aberrant translation a widespread characteristic of tumour cells, independent of the genetic make-up of the cancer. Therefore, therapeutic agents that target components of the protein synthesis apparatus hold promise as novel anticancer drugs that can overcome intra-tumour heterogeneity. In this Review, we discuss the role of translation in cancer, with a particular focus on the eIF4F (eukaryotic translation initiation factor 4F) complex, and provide an overview of recent efforts aiming to 'translate' these results to the clinic.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The natural product, silvestrol, and related compounds are selective and potent inhibitors of the RNA helicase and translation initiation factor eIF4A (Eukaryotic Translational Initiation Factor 4A, also known as DDX2) [20].”
From NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy (2021) · cites this paper as [20]
In the citing paper
“Our results build on studies in mouse models of other cancers, including lymphoma, leukemia, breast, prostate, and pancreatic cancer, supporting the tolerability and efficacy of eIF4A inhibitors (15, 17, 20, 21, 38).”
From Targeting eIF4A-dependent translation in genetically complex sarcoma (2026) · cites this paper as [38]
In the citing paper
“Many direct eIF4A/eIF4F mRNA targets have been identified and often encode proteins that drive proliferation, metastasis, and survival (11, 14, 15).”
From Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer (2023) · cites this paper as [14]
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Wolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2775 · Cited by 4,434
Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
Vogel, C., & Marcotte, E. M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3185 · Cited by 4,195
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
Research works printed but not linked: 5
- Hershey, J. W. B., Sonenberg, N. & Mathews, M. in Protein Synthesis and Translational Control (eds Hershey, J. W. B. et al.) (Cold Spring Harbor Laboratory Press, 2012)
- Pianese, G. Beitrag zur histologie und aetiologie der carcinoma histologische und experimentelle. Beitr. Pathol. Anat. Allg. Pathol. 142, 1–193 (in German) (1896). First evidence that dysregulated translation has a major role in cancer by demonstrating that cancer cells have hypertrophic and irregularly shaped nucleoli.
- De Benedetti, A. et al. CHO cells transformed by the translation factor elF-4E display increased c-Myc expression, but require overexpression of Max for tumorigenicity. Mol. Cell. Diff. 2, 347–371 (1994).
- Ron, D. & Harding, H. in Translational Control in Biology and Medicine Ch. 13 (eds Matthews, M. B. et al.) (Cold Spring Harbor Laboratory Press, 2007).
- Bissler, J. J. et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N. Engl. J. Med. 358, 140–151 (2008). · DOI · Paper page
Cited by
Items 801–899 of 899
Hermann, J. (2024) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00035765
Investigating the cooperation of APC and KRAS mutations in colorectal cancer
Gay, D. M. (2018) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.9089
Hung, Y., Ouyang, C., Ping, X., Qi, Y., Wang, Y.-C., Kung, H.-J., & Ann, D. K. (2023) · Figshare · doi:10.6084/m9.figshare.23084139
Wilde, B. R., Kaadige, M. R., Guillen, K. P., Butterfield, A., Welm, B. E., & Ayer, D. E. (2020) · Figshare · doi:10.6084/m9.figshare.13336351
Li, S., Shao, J., Lou, G., Wu, C., Liu, Y., & Zheng, M. (2021) · Figshare · doi:10.6084/m9.figshare.13684574
Iglesias‐Pedraz, J. M., Fossatti-Jara, D. M., Valle-Riestra-Felice, V., Cruz-Visalaya, S. R., Ayala Felix, J. A., & Comai, L. (2020) · Figshare · doi:10.6084/m9.figshare.13093873
García González, V. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Davyt Borthagaray, M. (2021) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Translational mechanisms of stem cell fate regulation in epidermal oncogene tolerance
Cai, Y. (2019) · ResearchWorks at the University of Washington (University of Washington)
Defining the role of RNA-binding proteins and their regulation by arginine methylation
Song, J. (2017) · eScholarship@McGill (McGill) · doi:10.82308/45743
Learning Genetic Networks Using Gaussian Graphical Model and Large-Scale Gene Expression Data
Zhao, H. (2020) · OhioLink ETD Center (Ohio Library and Information Network)
Contreras Bernal, L. (2023) · Deposito de Investigacion Universidad de Sevilla (University of Seville)
Ghahnavieh, L. E. (2024) · eScholarship@McGill (McGill) · doi:10.82308/53557
Rouya, C. (2015) · eScholarship@McGill (McGill) · doi:10.82308/45041
Unveiling the Dual Nature of Eukaryotic Initiation Factor 4A in Cap-dependent Translation Initiation
Suresh, P. (2024) · eScholarship@McGill (McGill) · doi:10.82308/19466
Modelowanie i analiza wybranych mechanizmów regulacji procesów wewnątrzkomórkowych
Kałużyńska, D. (2023) · Digital Library of the Silesian University of Technology (Silesian University of Technology)
Targeting RNA Structures that Control Protein Synthesis and RNA Stability
Walker, M. J. (2019) · ResearchWorks at the University of Washington (University of Washington)
Inhibition of mTOR induces chemoresistance in B-cell acute lymphoblastic leukemia
Vo, T.-T., Nguyen, D., Lui, B., Lu, M., Mallya, S., & Fruman, D. (2015) · eScholarship (California Digital Library)
Reprogramming eIF4A-Dependent mRNA Translation to Control Leishmania Infection
Cortazzo da Silva, L. (2024) · EspaceINRS (National Institute for Scientific Research (Canada))
The functional dichotomy of HuR is a key determinant of the fate of skeletal muscle
Mubaid, S. (2023) · eScholarship@McGill (McGill) · doi:10.82308/22780
Regulation of ribosome biogenesis by KRAS oncogene in Pancreatic Ductal Adenocarcinoma
Azman, M. (2023) · Queen Mary Research Online (Queen Mary University of London)
Anti-Cancer Effects by Interleukin 24
Zhong, X. (2021) · CUNY Academic Works (City University of New York)
Multi-task learning of transcriptomic signatures underlying cancer gene dependencies
Rentroia Pacheco, B. (. (2019) · Research Repository (Delft University of Technology)
Fernández-Calero, T. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Bases estructurales de la acción del factor de la iniciación eIF4F
Escamilla Aguilar, M. (2024) · DIGITAL.CSIC (Spanish National Research Council (CSIC))
Takdenti, M. (2023) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/26423
Dass, R. A. (2018) · eCommons (Cornell University)
DISCOVERY AND FUNCTIONAL CHARACTERIZATIONS OF PLAG1 IN HUMAN HEMATOPOEITIC STEM AND PROGENITOR CELLS
Belew, M. S. (2017) · MacSphere (McMaster University) · doi:10.71548/10279
Therapeutic strategies targeting hepatocellular carcinoma
Marwa, B. M. (2018) · doi:10.82308/15141
Mechanistic Insights into Molecular Staples as Potent Inhibitors of DEAD-box RNA Helicases
Naineni, S. K. (2024) · eScholarship@McGill (McGill) · doi:10.82308/27684
Dreno, L., Ousalem, F., Albornoz-Loaiza, A., CELIK, B., Tiraboschi, C., Claps, G., Al-Nakouzi, N., Compagno, D., Dayris, T., Aglave, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.18.700172
Rinaldi, L., Senatore, E., Moraca, F., DˈAmbrosio, C., Rizzo, F. M., Alexandrova, E., Memoli, D., Weisz, A., Avolio, R., Borzacchiello, D., et al. (2026) · Cell Death and Differentiation · doi:10.21203/rs.3.rs-8873259/v1
Investigating WDR12 as a Therapeutic Target in Breast Cancer
Kim, J. S. (2023) · TSpace (University of Toronto)
Conséquences traductionnelles de la perte de 4E-BP1 dans l'adénocarcinome pancréatique
Müller, D. (2016) · theses.fr (ABES) · doi:10.70675/1f894fb2zc2daz446fza7f2z2b28408eb6e2
Manier, S. (2017) · theses.fr (ABES) · doi:10.70675/e20f6002z0753z4a05zb5efz887c59b45515
Synthèse de nouveaux agents anticancéreux
Hamdan, H. A. (2018) · theses.fr (ABES) · doi:10.70675/9195b726z7245z42f8za28cz127953446494
Rôle de la kinase ARAF dans le mélanome cutané muté NRAS
Estrada, C. (2020) · theses.fr (ABES) · doi:10.70675/e84b4f6az1676z4c2dz80e4zd8668460d3c5
Long, F. N. V. (2019) · theses.fr (ABES) · doi:10.70675/12a8367cz6b6bz4592zbd98zf68b8cd5151d
Rôle du facteur d'initiation eIF3 dans la traduction de l'ARNm de l'histone H4
Hayek, H. (2019) · theses.fr (ABES) · doi:10.70675/b34f5d54z11cfz46c1zae6ezf5128736d001
Translatome-based classification of pancreatic cancer
Shin, S. (2020) · theses.fr (ABES) · doi:10.70675/09efa5edz6f6ez4463z90eaz76d4c6c23a9d
Reprogrammation traductionnelle par eIF3 liée à la résistance aux traitements des glioblastomes
Bertorello, J. (2020) · theses.fr (ABES) · doi:10.70675/45fcb8f2zdec5z4e20za81dz55df467b56a5
Characterization of cellular heterogeneity in Diffuse Low Grade Glioma
Augustus, M. (2020) · theses.fr (ABES) · doi:10.70675/037c23a4z44ddz4bb7z999ezb0c178c35170
Rôle de la traduction et du ribosome dans la résistance aux thérapies dans les cancers
Mourksi, N. (2023) · theses.fr (ABES) · doi:10.70675/dd7b577cz67a3z4a52zb4adz2057147efb7f
Serafini, M. (2024) · theses.fr (ABES) · doi:10.70675/ab8b1f5az3c15z4b5fzba28z247b40b8c7e0
Romagnoli, A., Gutierrez, O. J. A., Raniolo, S., Gori, A., Foka, K., Luca, A. D., Sgrignani, J., Rexha, J., Roscioni, A., Bergamaschi, G., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.06.722988
Pardo, L., Moore, M., Deshmukh, R. S., Powley, I. R., Waldron, J. A., Kruspig, B., McGarry, L., Dolma, L., Campos, A. V., Wood, C., et al. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02680-z
“Oncogenic events during tumour progression converge on the protein synthesis machinery to sculpt mRNA translation landscapes that drive cancer cell growth, survival and invasiveness [1, 2].”
Cárdenas, B., Suárez, S. N., Baroja, I., Mendez, A., Bosch-i-Crespo, P., Gallardo-Martínez, C., Ramírez-Pedraza, M., Delgado, M. E., Morató, L., Belloc, E., et al. (2026) · Gut · doi:10.1136/gutjnl-2026-338325
“26 27 31 Recent work has identified CPEB4 as a critical regulator of hepatocyte adaptation to chronic metabolic and proteotoxic stress through its role in translational control.”
Oliveto, S., Ferrari, I., Gruarin, P., Cordiglieri, C., Miluzio, A., Curti, S., Manfrini, N., Pesce, E., Mattinzoli, D., Ikeata, M., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9859684/v1
Rios-Fuller, T. J., Saavedra, H. I., & Schneider, R. J. (2026) · Disease and Therapeutics · doi:10.1016/j.dist.2026.100018
A Dimeric Protein-RNA Glue Promotes Multivalent eIF4A-RNA Assembly
Liu, J., Moore, M. K., Lou, K., Wassarman, D. R., Arab, A., Ojeda, S., Karakyriakou, B., Koglin, A.-S., Ott, C. J., Gilbert, L. A., et al. (2026) · ACS Central Science · doi:10.1021/acscentsci.6c00662
Vega-Hernández, G., & Garner, A. L. (2026) · RSC Chemical Biology · doi:10.1039/d6cb00136j
“99 104 The exact role of internal m 7 G modifications within mRNA remains elusive.”
Sexual dimorphism of autism-like phenotypes in microglial eIF4E overexpression micePreprint
Niu, C., An, J. J., Masterson, H. V., & Xu, B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.03.748596
Schcolnik‐Cabrera, A., Takdenti, M., Nejad, A. S. H., Nouhi, Z., St-Amand, S., Capdevielle, C., Issa, D., Riaud, M., Rose, A. A. N., Khacho, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.03.749206
Self-citationInterpretable Deep Learning for Elucidating Translation Elongation Dynamics
Nallapareddy, V. (2026) · Infoscience (Ecole Polytechnique Fédérale de Lausanne) · doi:10.5075/epfl-thesis-12021
Defects in ribosomes and translational control in lymphoid leukemia and lymphoma
Caruso, M., Pasau, N., Herranz, Ó., & Keersmaecker, K. D. (2026) · Seminars in Hematology · doi:10.1053/j.seminhematol.2026.09.002
Gong, Z., Dong, K., Chen, W., Liu, Y., Li, M., Ma, W., Zheng, H., Zhang, H. X., Di, S., Zhou, W., et al. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101476
A context‐dependent modulatory role for eIF6 in acquired resistance to vemurafenib in melanoma
Kyriakopoulos, G., Petropoulou, A., Anastogianni, A., Bania, A., Stamatakis, V., Alexiou, A., Day, C., Merlino, G. T., Grafanaki, K., & Stathopoulos, C. (2026) · FEBS Letters · doi:10.1002/1873-3468.70467
Complementary fish models for brain ageing: insights from killifish and zebrafish
Leggieri, A., & Bähler, J. (2026) · Essays in Biochemistry · doi:10.1042/ebc20260052
Mechanistic role of eIF4E in the hallmarks of cancer: A translational control perspective
Effiong, M. E., Effiong, P. E., Roy, S., Okafor, C. E., Schober, J. M., In, L. L. A., & Patel, B. A. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105623
From mRNA to protein: Translation as a key layer of gene expression
Liauzun, M., Solórzano, J., Bras, M. L., Bousquet, C., & Martineau, Y. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-19001-8.00002-7
Muto, D., Matsuo, T., Seydel, T., Endo, A., Turbant, F., Hippo, Y., Suenaga, Y., & Peters, J. (2026) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.6c02647
METTL10 trimethylation of eEF1A at K318 enhances protein synthesis and tumorigenesis
Buie, L., Hausmann, S., Park, J.-H., Ikram, S., Chasan, T., Yang, X., Flores, N. M., Mazur, P., & Gozani, O. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113635
Identification and characterisation of Mnk inhibitors as potential ant-cancer agents
K.C. Basnet, S. (2017) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
RAPPL-Seq Enables Rapid, High-Sensitivity Ribosome Profiling of Scarce SamplesPreprint
Park, A., Szkop, K. J., Lim, C., Erath, J., Huang, J., Mathios, D., Dai, Z., He, X., Pavlovic‐Djuranovic, S., Larsson, O. S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.20.760540
BindingDB Entry 50018392: Inhibitors of Eukaryotic Translational Machinery as Therapeutic Agents.
BindingDB (2024) · UC San Diego · doi:10.7270/q2t43z96
BindingDB (2020) · UC San Diego · doi:10.7270/q2qj7kr6
BindingDB Entry 50017813: Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor.
BindingDB (2023) · UC San Diego · doi:10.7270/q200065b
BindingDB Entry 50018671: Discovery of an eIF4A Inhibitor with a Novel Mechanism of Action.
BindingDB (2024) · UC San Diego · doi:10.7270/q22j6h3k
Methylated eEF1A selectively decodes mRNA to shape cancer proteomes
Liu, S., Cruz-Navarrete, F. A., Hausmann, S., Szkop, K. J., Ikram, S., Brady, R. A., Lu, X., Dong, R., Vu, J., Flores, N. M., et al. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-02085-6
Rewired decoding fuels KRAS-driven cancer growth and drug resistance
(2026) · Nature Cell Biology · doi:10.1038/s41556-026-02089-2
Zafirov, D., Giovinazzo, N., Lecampion, C., Field, B., Ducassou, J. N., Couté, Y., Browning, K. S., Robaglia, C., & Gallois, J.-L. (2023) · doi:10.1371/journal.ppat.1011417.r001
McLean, D. T., Meudt, J. J., Rivera, L. D. L., Schomberg, D. T., Pavelec, D. M., Duellman, T. T., Buehler, D. G., Schwartz, P. B., Graham, M., Lee, L. M., et al. (2023) · doi:10.3389/fonc.2023.1253659.s002
Zhang, F., Waheed, S., Armato, U., Wu, J., Zhang, C., & Li, Z. (2022) · doi:10.3389/fonc.2022.848346.s001
Xue, C., Gu, X., Li, G., Bao, Z., & Li, L. (2021) · doi:10.3389/fcell.2021.711965.s002
Metadata
- Authors
- Bhat, M., Robichaud, N., Hulea, L., Sonenberg, N., Pelletier, J., & Topisirovic, I.
- Affiliations
- McGill University Health Centre (CA)
- McGill University (CA)
- Jewish General Hospital (CA)
- Corresponding author
- Sonenberg, Nahum
- Pelletier, Jerry
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-03-06
- Volume
- 14
- Issue
- 4
- Pages
- 261-278
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2040885133
- Cited by
- 799
- References
- 291
- Citations by year
- 2026: 40 · 2025: 44 · 2024: 69 · 2023: 77 · 2022: 58 · 2021: 75 · 2020: 92 · 2019: 70 · 2018: 89 · 2017: 99 · 2016: 65 · 2015: 19
- FWCI
- 8.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@McGill (McGill) (submittedVersion)
- Funders
- Howard Hughes Medical Institute (55007654)
- Canadian Institutes of Health Research (MOP115-195, MOP#115126, 106530_1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Keywords
- mRNA translation, translation machinery, cancer, eIF4F, translation initiation, oncogenes, tumour suppressor, anticancer agents, intra-tumour heterogeneity, drug development
- MeSH terms
- Animals, Antineoplastic Agents, Humans, Neoplasms, RNA, Messenger, Protein Biosynthesis, Gene Expression Regulation, Neoplastic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.